Buckingham Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Buckingham Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$446.73 - $548.2 $246,594 - $302,606	-552 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $134,880 - $171,450	-282 Reduced 33.81%	552 $267,000
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $117,121 - $141,515	-215 Reduced 20.5%	834 $467,000
Q2 2020 Jul 20, 2020	SELL	$493.32 - $643.92 $269,846 - $352,224	-547 Reduced 34.27%	1,049 $654,000
Q1 2020 May 06, 2020	SELL	$336.18 - $494.43 $231,628 - $340,662	-689 Reduced 30.15%	1,596 $779,000
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $234,929 - $322,669	-857 Reduced 27.28%	2,285 $858,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $546 - $636	2 Added 0.06%	3,142 $872,000
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $233,688 - $323,559	780 Added 33.05%	3,140 $983,000
Q1 2019 May 07, 2019	BUY	$372.08 - $439.57 $878,108 - $1.04 Million	2,360 New	2,360 $969,000

1,480

85.5M

908K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $89.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Buckingham Capital Management, Inc. with notifications on news.